Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $27.6100 (-3.76%) ($27.1400 - $28.5500) on Thu. Jun. 25, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.51% (three month average) | RSI | 31 | Latest Price | $27.6100(-3.76%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA declines -1.6% a day on average for past five trading days. | Weekly Trend | IOVA declines -3% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(48%) XBI(45%) ARKG(44%) IWO(42%) ARKK(40%) | Factors Impacting IOVA price | IOVA will decline at least -2.255% in a week (0% probabilities). VIXM(-23%) UUP(-17%) VXX(-12%) TBT(-5%) UNG(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.255% (StdDev 4.51%) | Hourly BBV | 0 () | Intraday Trend | -3.2% | | | |
|
1 - 5 Day Possible Target | $20.56(-25.53%) | Resistance Level | $30.67 | 5 Day Moving Average | $29.46(-6.28%) | 10 Day Moving Average | $29.63(-6.82%) | 20 Day Moving Average | $30.67(-9.98%) | To recent high | -32.7% | To recent low | 0% | Market Cap | $4.043b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |